GENEVA, Aug. 7 -- CHIESI FARMACEUTICI S.P.A. filed a patent application (EP2026/051150) for “TREATMENT OF PROGRESSIVE CHRONIC INTERSTITIAL LUNG DISEASE WITH AN ANTI-TG2 ANTIBODY”. With publication no. WO/2026/162317, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61P 11/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....